Article Details
Retrieved on: 2024-12-17 20:22:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On October 22, 2024, Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk's semaglutide products.
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here